How Often Does Atrial Fibrillation Occur?

Atrial fibrillation is the most common heart rhythm disorder in the world, affecting roughly 50 to 60 million people globally as of the early 2020s. In the United States alone, the overall prevalence sits near 4% of adults, but that number obscures enormous variation by age, race, lifestyle, and whether someone has ever been screened. The real frequency of atrial fibrillation depends heavily on how and where you look for it, and large portions of cases go undetected entirely.

Global and National Prevalence

The Global Burden of Disease Study 2021 estimated that about 52.5 million people were living with atrial fibrillation or atrial flutter worldwide, confirming its status as the single most common arrhythmia on the planet.¹ An earlier estimate from the GBD 2019 data put the figure even higher, at over 59 million, though differences in methodology and year account for the gap.² Either way, the trajectory is steeply upward: global prevalence roughly doubled from about 33.5 million in 2010 to the current figures.

In the United States, a recent analysis of nearly five million patients between 2019 and 2023 found an overall prevalence of about 3.9% among adults.³ That percentage sounds modest until you realize it translates into millions of people, and the number keeps climbing. Projections from a U.S. claims database estimated that diagnosed cases would grow from about 5.2 million in 2010 to 12.1 million by 2030, with annual new diagnoses doubling in the same period.⁴ European data tell a similar story: a study of the Catalan and Spanish populations projects the number of people with atrial fibrillation to double by 2050, reaching a prevalence around 6.5%.⁵

What is driving these increases? Mostly aging populations. When researchers adjust for age, the rate at which people develop atrial fibrillation has stayed remarkably stable over decades.² People are not becoming inherently more prone to the condition. They are simply living longer, and atrial fibrillation is overwhelmingly an age-related phenomenon. Improved detection through wider use of ECGs and wearable devices also contributes to higher raw counts, though the fundamental biology has not changed.

How Age and Sex Shape the Numbers

Age is the single strongest predictor of atrial fibrillation. Among adults under 50, prevalence is vanishingly small, around 0.26% in U.S. data.³ After 65, the rate climbs steeply. An older but widely cited analysis found prevalence of about 5.9% in people over 65, with roughly 70% of all atrial fibrillation patients falling between 65 and 85 years old.⁶ Among those who reach 90, about one in four has the condition.³

Sex plays a subtler role. Men are diagnosed more frequently at younger ages, and in the U.S. dataset about 55% of patients were male.³ But because women live longer on average, the balance shifts with age. Past 75, about 60% of people with atrial fibrillation are women, and the total number of men and women living with the condition is roughly equal.⁶

Your Lifetime Chance of Developing It

Prevalence at any moment is one thing, but the lifetime risk paints a more striking picture. The landmark Framingham Heart Study estimated that for men and women aged 40 and older, the lifetime risk of developing atrial fibrillation is about one in four.⁷ That figure held surprisingly steady even at older starting ages because, while remaining lifespan was shorter, the rate of new cases accelerated fast enough to compensate.

More recent Danish data suggests those odds have risen. Looking at people aged 45 across the period from 2000 to 2022, the overall lifetime risk was about 28%, but that figure climbed from roughly 24% in the first decade to about 31% in the second.⁸ An American cohort study from the ARIC data found that lifetime risk varied by race: roughly one in three for white participants compared to about one in five for Black participants.⁹ Whether those racial differences reflect true biological variation or differences in detection is an important and unresolved question, covered below.

How Much Goes Undetected

All the prevalence numbers above come from diagnosed cases, but atrial fibrillation often produces no symptoms at all. Many people first learn they have it only when they show up at the hospital with a stroke. Screening studies have found that when you actively look for undiagnosed atrial fibrillation in the general population, you pick up about 1% of people, rising to about 1.4% in those over 65.¹⁰ Among higher-risk groups like people with heart failure or implanted cardiac devices, prolonged monitoring reveals silent atrial arrhythmias in at least 10%, and those individuals face roughly 2.5 times the risk of stroke.¹⁰

A Swedish screening study of 75-year-olds illustrates this well. Among those who underwent a standard ECG, about 1% had previously unknown atrial fibrillation. But when the same population used a handheld ECG recorder intermittently over two weeks, the detection rate jumped to 7.4% among people with two or more stroke risk factors.¹¹ The difference between a snapshot and sustained monitoring is enormous, because atrial fibrillation often comes and goes in episodes.

Wearable Devices and Detection

Consumer smartwatches have entered this detection gap. A recent meta-analysis of 26 studies covering over 17,000 patients found that smartwatches collectively achieve about 95% sensitivity and 97% specificity for detecting atrial fibrillation, with comparable accuracy whether they use optical pulse sensors or onboard ECG features.¹² Those are impressive numbers, but the catch is that most smartwatch wearers are young, healthy, and at very low risk. In the large Apple Heart Study, only about 0.5% of participants received an irregular-pulse notification over roughly four months of monitoring. Among those who followed up with an ECG patch, about a third actually had confirmed atrial fibrillation.¹³ The technology works well when atrial fibrillation is present, but the rarity of the condition in younger populations means false alarms and follow-up burdens remain a concern for mass screening.

Racial and Ethnic Variation

One of the more puzzling patterns in atrial fibrillation epidemiology is that diagnosed rates are consistently highest in white populations and lowest in Black populations, with Hispanic and Asian individuals falling in between.¹⁴ Data from the Multi-Ethnic Study of Atherosclerosis (MESA) illustrate these gaps: after about 14 years of follow-up, clinically detected atrial fibrillation appeared in 11.3% of white participants, 9.9% of Chinese American participants, 7.8% of Hispanic participants, and 6.6% of Black participants.¹⁵

Here is where it gets interesting. When the same MESA participants were given 14-day ambulatory ECG monitors, the actual rates of monitor-detected atrial fibrillation were similar across all four racial groups, ranging from about 5% to 7% with no statistically significant differences.¹⁵ This strongly suggests that the racial gap in diagnosed atrial fibrillation reflects differences in healthcare access, screening frequency, and how often people interact with the medical system rather than any dramatic biological difference in who actually develops the arrhythmia. Reported incidence data from the same MESA cohort confirmed that white individuals had the highest overall reported incidence, while Hispanic and Black participants had lower rates, but detection method and healthcare setting influenced these gaps substantially.¹⁶

The Role of Socioeconomic Deprivation

Race is tangled up with socioeconomic factors, which independently affect how often atrial fibrillation shows up in the data. A large UK population study found that people living in the most deprived areas were about 20% more likely to be diagnosed with atrial fibrillation than those in the most affluent areas, even after adjusting for age and sex.¹⁷ People in deprived areas also developed atrial fibrillation at younger ages and had more co-existing conditions at the time of diagnosis.¹⁸ Social factors like financial resources, healthcare access, language barriers, and health literacy all shape when and whether atrial fibrillation gets caught.¹⁹

Atrial Fibrillation After Surgery

One setting where atrial fibrillation crops up with striking frequency is after heart surgery. New-onset atrial fibrillation is the most common complication of cardiac surgery, appearing in up to half of patients.²⁰ A meta-analysis of 59 studies covering nearly 200,000 patients found a cumulative incidence of about 26%, though the range was wide, from about 7% to over 53% depending on the type of surgery and how carefully monitoring was done.²¹ Valve surgery carries the greatest risk. Post-operative atrial fibrillation also occurs after non-cardiac surgery, though at lower rates, and advanced age is the major risk factor in both settings.²²

Clinical Subtypes

Not everyone with atrial fibrillation experiences it the same way. The arrhythmia is classified into three broad types based on how it behaves over time. A large international registry of nearly 10,000 patients in routine clinical care found that about 27% had paroxysmal atrial fibrillation (episodes that start and stop on their own), about 24% had persistent (episodes lasting longer than a week or needing intervention to stop), and about 50% had permanent atrial fibrillation (a continuous rhythm that is accepted rather than treated).²³ In practice, many patients progress from paroxysmal to persistent to permanent over years, which is part of why early detection and treatment matter.

Modifiable Risk Factors

Some of the factors that make atrial fibrillation more likely are things you can change. Obesity, obstructive sleep apnea, and alcohol consumption all independently increase the risk.²⁴ A recent review estimated that each unit increase in body mass index raises the risk of atrial fibrillation by about 50%, while sustained weight loss can reverse some of the structural heart changes that promote the arrhythmia. Treating sleep apnea with CPAP has been shown to cut recurrence roughly in half after procedures like cardioversion or ablation. Alcohol’s effects appear dose-dependent: the more you drink, the more the risk climbs.²⁵

The Endurance Athlete Paradox

Exercise is generally protective against heart disease, but there is a striking exception for extreme endurance athletes. A meta-analysis found roughly a five-fold increased risk of atrial fibrillation in middle-aged endurance athletes, with a strong male predominance.²⁶ The effect appears to follow a U-shaped curve: moderate exercise lowers your risk compared to being sedentary, but accumulating more than roughly 2,000 lifetime hours of intense training is associated with nearly a four-fold increase.²⁷ Other analyses have placed the range of increased risk for endurance sport at somewhere between two and ten times that of the general population.²⁸ The mechanism likely involves chronic stretching and scarring of the atria from years of high cardiac output, combined with changes in the autonomic nervous system. For recreational exercisers, this is not a worry; it mainly applies to people with decades of intense competitive training.

How Much Atrial Fibrillation Raises Stroke Risk

The main reason the frequency of atrial fibrillation matters clinically is its tight link to stroke. But the relationship is not binary. How much time your heart spends in atrial fibrillation, often called the “burden,” matters as much as whether you have the condition at all. A study of over 21,000 patients with implanted cardiac devices found that stroke risk climbed with both the duration of atrial fibrillation episodes and the patient’s overall stroke risk score. For people with moderate risk scores, more than about six minutes of device-detected atrial fibrillation was enough to push annual stroke risk above 1%.²⁹

The ASSERT trial reinforced this with a threshold effect: episodes of subclinical atrial fibrillation lasting more than 24 hours were associated with about a three-fold increase in stroke or systemic embolism, while shorter episodes did not show a statistically significant increase.³⁰ A meta-analysis of multiple device-monitoring studies confirmed an overall 2.4-fold increased stroke risk in patients whose episodes exceeded defined duration thresholds.³¹ The practical implication is that brief, rare episodes pose far less danger than frequent or sustained ones, which matters for deciding who needs blood thinners.

Recurrence After Treatment

Even after catheter ablation, one of the most definitive treatments for atrial fibrillation, the condition comes back in a substantial fraction of patients. Estimates put recurrence at 20% to 40% after a first ablation procedure.³² A large study of over 23,000 patients who underwent ablation found that about 17% went on to have at least one repeat procedure.³³ Danish registry data paints an even longer-term picture: five-year cumulative recurrence for the earliest-treated group was about 43%, climbing to around 58% when ablation was delayed.³⁴ Getting ablation sooner rather than later appears to improve the odds. Regardless, the high recurrence rates mean that for many people, atrial fibrillation is not a one-time event but a chronic, recurring condition that requires ongoing management.

Genetic Underpinnings

Genetics play a meaningful role in who develops atrial fibrillation. A large-scale heritability study estimated that about 22% of the variation in atrial fibrillation risk can be attributed to common genetic variants, a figure that held for both early-onset and older-onset cases, and for both men and women.³⁵ In younger patients, the genetic signal can be especially strong. A study of nearly 1,300 people with early-onset atrial fibrillation found that about 10% carried a clearly disease-associated genetic variant, with the yield highest in those diagnosed before age 30, where nearly 17% had such a variant.³⁶ Many of these variants overlap with genes linked to inherited cardiomyopathies, meaning that atrial fibrillation in a young person can sometimes be the first visible sign of a more serious underlying heart condition.³⁷

Emergency Department Burden

The frequency of atrial fibrillation shows up not just in population studies but in the strain it places on hospitals. Between 1993 and 2004, U.S. emergency department visits for atrial fibrillation roughly doubled, from about 300,000 per two-year period to 564,000, with about 64% of those visits resulting in hospital admission.³⁸ That upward trend continued: between 2007 and 2014, annual ED visits and admissions for atrial fibrillation rose even further, despite some reduction in the proportion of patients admitted.³⁹ The economic burden is substantial and growing, and it reflects both the rising prevalence of atrial fibrillation in an aging population and the fact that the condition frequently causes acute symptoms like rapid heartbeat, dizziness, or shortness of breath that send people to the ER even when the arrhythmia itself is not immediately life-threatening.